StockData
Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc. (CRBU) stock

CRBUNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3073% below fair value
$0.35−0.01 (-2.51%)

Close on Nov 16, 2026Market cap $37.82MP/E –Yield –

Caribou Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Caribou Biosciences's enterprise value was -$72.39M on Nov 11, 2026, against $22.13M a year earlier. Over the last 5 years it ranged from -$197.78M to $470.41M, with a median of $23.46M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$72.39M–
2025Dec 31, 2025-$10.59M–
2024Dec 31, 2024-$137.02M-224.6%
2023Dec 29, 2023$110.01M+172.3%
2022Dec 30, 2022$40.40M-91.4%
2021Dec 31, 2021$470.41M–

More Caribou Biosciences figures

See a number that looks wrong?